InSite Vision, Inc.
Press Releases
Webcast ImageWebcast
InSite Vision Incorporated at Roth Conference (Replay)
03/20/13 at 12:00 p.m. PT
Webcast ImageWebcast
Q1 2013 InSite Vision Incorporated Earnings Conference Call (Replay)
05/07/13 at 4:30 p.m. ET
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
12/19/11InSite Vision Names Tim McInerney Chairman of the BoardPrinter Friendly Version
11/28/11InSite Vision Wins Patent Interference Litigation Against the University of California, San FranciscoPrinter Friendly Version
11/21/11InSite Vision Reports Completion of Oral Arguments in Patent Interference LitigationPrinter Friendly Version
11/21/11InSite Vision to Present at the 23rd Annual Piper Jaffray Health Care ConferencePrinter Friendly Version
11/16/11InSite Vision Initiates Phase 3 DOUBle Study of AzaSite Plus(TM) and DexaSite(TM) for BlepharitisPrinter Friendly Version
11/01/11InSite Vision Announces Departure of Evan S. Melrose, M.D. from its Board of DirectorsPrinter Friendly Version
10/27/11InSite Vision Reports Third Quarter 2011 Financial ResultsPrinter Friendly Version
10/19/11InSite Vision to Report Third Quarter 2011 Financial Results on October 27, 2011Printer Friendly Version
10/13/11InSite Vision to Present at the Newsmakers in the Biotech Industry ConferencePrinter Friendly Version
10/04/11InSite Vision Announces Positive Phase 2 PK Results for BromSite(TM) (ISV-303) for the Reduction of Pain and Inflammation After Cataract SurgeryPrinter Friendly Version
09/26/11InSite Vision Selects Quintiles as Contract Research Organization for the DOUBle Phase 3 Clinical Trial of AzaSite Plus(TM) and DexaSite(TM)Printer Friendly Version
09/21/11InSite Vision to Present at the Sixth Annual JMP Securities Healthcare ConferencePrinter Friendly Version
09/20/11InSite Vision Appoints New Board MemberPrinter Friendly Version
09/15/11InSite Vision Establishes Scientific Advisory BoardPrinter Friendly Version
08/29/11InSite Vision to Present at the Rodman & Renshaw Annual Global Investment Conference in New YorkPrinter Friendly Version
08/15/11InSite Vision Appoints New Board MemberPrinter Friendly Version
08/02/11InSite Vision Reports Second Quarter 2011 Financial ResultsPrinter Friendly Version
07/26/11InSite Vision to Report Second Quarter 2011 Financial Results on August 2, 2011Printer Friendly Version
07/13/11InSite Vision Announces Pricing of $22.2 Million FinancingPrinter Friendly Version
05/31/11InSite Vision Launches www.AzaSitePlus.comPrinter Friendly Version
05/27/11InSite Vision to Webcast Annual Meeting of Stockholders on June 1, 2011Printer Friendly Version
05/26/11InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against SandozPrinter Friendly Version
05/25/11InSite Vision Receives Special Protocol Assessment from the FDA for the DOUBle Phase 3 Clinical Trial of AzaSite Plus(TM) and DexaSite(TM)Printer Friendly Version
05/12/11InSite Vision Reports First Quarter 2011 Financial ResultsPrinter Friendly Version
05/05/11InSite Vision to Report First Quarter 2011 Financial Results on May 12, 2011Printer Friendly Version
04/14/11InSite Vision Updates Special Protocol Assessment Submission to FDA for Phase 3 Trial of AzaSite Plus(TM) and DexaSite(TM)Printer Friendly Version
03/22/11InSite Vision Announces Positive Phase 1/2 Results for ISV-303 for the Reduction of Pain and Inflammation after Cataract SurgeryPrinter Friendly Version
03/15/11InSite Vision Announces Annual Shareholder Meeting to be Held on June 1, 2011Printer Friendly Version
03/01/11InSite Vision to Present Data on Multiple Clinical-Stage Candidates at ARVO's 2011 Annual MeetingPrinter Friendly Version
02/24/11InSite Vision Reports Full Year and Fourth Quarter 2010 Financial ResultsPrinter Friendly Version
02/22/11InSite Vision Announces Publication of Preclinical Data Showing that DuraSite(R)-Enabled Bromfenac Attains Higher Concentrations in Ocular Tissues Compared to the Commercially Available DrugPrinter Friendly Version
02/17/11InSite Vision to Report Fourth Quarter and Year-End 2010 Financial Results on February 24, 2011Printer Friendly Version
02/07/11InSite Vision to Present at the 13th Annual BIO CEO & Investor ConferencePrinter Friendly Version
01/11/11InSite Vision Files IND for ISV-101 with the U.S. Food and Drug Administration for the Treatment of Dry Eye DiseasePrinter Friendly Version
01/05/11InSite Vision Completes Patient Enrollment in ISV-303 Phase 1/2 Clinical Study for Post-Surgical Ocular Pain and SwellingPrinter Friendly Version